"T's and blues". 1982

J S Halpern, and J W Davis

UI MeSH Term Description Entries
D010423 Pentazocine The first mixed agonist-antagonist analgesic to be marketed. It is an agonist at the kappa and sigma opioid receptors and has a weak antagonist action at the mu receptor. (From AMA Drug Evaluations Annual, 1991, p97) Fortral,Lexir,Pentazocine Hydrochloride,Pentazocine Lactate,Talwin,Hydrochloride, Pentazocine,Lactate, Pentazocine
D011307 Drug Prescriptions Directions written for the obtaining and use of DRUGS. Drug Prescribing,Drug Prescription,Drug Prescribings,Prescribing, Drug,Prescribings, Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013287 Illicit Drugs Drugs that are manufactured, obtained, or sold illegally. They include prescription drugs obtained or sold without prescription and non-prescription drugs. Illicit drugs are widely distributed, tend to be grossly impure and may cause unexpected toxicity. Club Drug,Drugs, Illegal,Illegal Drug,Illegal Drugs,Illicit Drug,Recreational Drug,Recreational Drugs,Street Drug,Street Drugs,Club Drugs,Drug, Club,Drug, Illegal,Drug, Illicit,Drug, Recreational,Drug, Street,Drugs, Club,Drugs, Illicit,Drugs, Recreational,Drugs, Street
D014309 Tripelennamine A histamine H1 antagonist with low sedative action but frequent gastrointestinal irritation. It is used to treat ASTHMA; HAY FEVER; URTICARIA; and RHINITIS; and also in veterinary applications. Tripelennamine is administered by various routes, including topically. Azaron,Histantin,Pyribenzamine,Tripelennamine Citrate,Tripelennamine Citrate (1:1),Tripelennamine Hydrochloride,Tripelennamine Maleate,Tripelennamine Maleate (1:1),Tripelennamine Monohydrochloride,Vetibenzamin
D019966 Substance-Related Disorders Disorders related to substance use or abuse. Chemical Dependence,Drug Abuse,Drug Addiction,Drug Dependence,Drug Habituation,Drug Use Disorder,Drug Use Disorders,Organic Mental Disorders, Substance-Induced,Substance Abuse,Substance Dependence,Substance Related Disorder,Substance Use,Substance Use Disorder,Substance Use Disorders,Prescription Drug Abuse,Substance Addiction,Abuse, Drug,Abuse, Prescription Drug,Abuse, Substance,Addiction, Drug,Addiction, Substance,Chemical Dependences,Dependence, Chemical,Dependence, Drug,Dependence, Substance,Dependences, Chemical,Disorder, Drug Use,Disorder, Substance Related,Disorder, Substance Use,Disorders, Substance Related,Drug Abuse, Prescription,Habituation, Drug,Organic Mental Disorders, Substance Induced,Related Disorder, Substance,Related Disorders, Substance,Substance Abuses,Substance Uses,Use, Substance

Related Publications

J S Halpern, and J W Davis
July 1978, JAMA,
J S Halpern, and J W Davis
January 1985, Psychiatric medicine,
J S Halpern, and J W Davis
September 1980, JAMA,
J S Halpern, and J W Davis
April 1983, JAMA,
J S Halpern, and J W Davis
January 1986, Advances in alcohol & substance abuse,
J S Halpern, and J W Davis
June 1982, Neurology,
J S Halpern, and J W Davis
March 1987, North Carolina medical journal,
J S Halpern, and J W Davis
July 1982, American journal of diseases of children (1960),
J S Halpern, and J W Davis
October 1984, The Journal of pharmacology and experimental therapeutics,
J S Halpern, and J W Davis
January 1982, The American journal of drug and alcohol abuse,
Copied contents to your clipboard!